Mutharasan R Kannan, Thaxton C Shad, Berry Jarett, Daviglus Martha L, Yuan Chun, Sun Jie, Ayers Colby, Lloyd-Jones Donald M, Wilkins John T
Department of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
Department of Urology and Institute of BioNanotechnology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.
J Lipid Res. 2017 Mar;58(3):600-606. doi: 10.1194/jlr.P069039. Epub 2017 Jan 3.
HDL efflux capacity and HDL particle size are associated with atherosclerotic CVD (ASCVD) events in middle-aged individuals; however, it is unclear whether these associations are present in older adults. We sampled 402 Chicago Healthy Aging Study participants who underwent a dedicated carotid MRI assessment for lipid-rich necrotic core (LRNC) plaque. We measured HDL particle size, HDL particle number, and LDL particle number with NMR spectroscopy, as well as HDL efflux capacity. We quantified the associations between HDL particle size and HDL efflux using adjusted linear regression models. We quantified associations between the presence of LRNC and HDL and LDL particle number, HDL particle size, and HDL efflux capacity using adjusted logistic regression models. HDL efflux capacity was directly associated with large (β = 0.037, < 0.001) and medium (β = 0.0065, = 0.002) HDL particle concentration and inversely associated with small (β = -0.0049, = 0.018) HDL particle concentration in multivariable adjusted models. HDL efflux capacity and HDL particle number were inversely associated with prevalent LRNC plaque in unadjusted models (odds ratio: 0.5; 95% confidence interval: 0.26, 0.96), but not after multivariable adjustment. HDL particle size was not associated with prevalent LRNC. HDL particle size was significantly associated with HDL efflux capacity, suggesting that differences in HDL efflux capacity may be due to structural differences in HDL particles. Future research is needed to determine whether HDL efflux is a marker of ASCVD risk in older populations.
高密度脂蛋白(HDL)的流出能力和HDL颗粒大小与中年个体的动脉粥样硬化性心血管疾病(ASCVD)事件相关;然而,这些关联在老年人中是否存在尚不清楚。我们对402名芝加哥健康老龄化研究参与者进行了抽样,这些参与者接受了针对富含脂质的坏死核心(LRNC)斑块的专门颈动脉磁共振成像(MRI)评估。我们使用核磁共振波谱法测量了HDL颗粒大小、HDL颗粒数量和低密度脂蛋白(LDL)颗粒数量,以及HDL流出能力。我们使用调整后的线性回归模型量化了HDL颗粒大小与HDL流出之间的关联。我们使用调整后的逻辑回归模型量化了LRNC的存在与HDL和LDL颗粒数量、HDL颗粒大小以及HDL流出能力之间的关联。在多变量调整模型中,HDL流出能力与大(β = 0.037,P < 0.001)和中(β = 0.0065,P = 0.002)HDL颗粒浓度直接相关,与小(β = -0.0049,P = 0.018)HDL颗粒浓度呈负相关。在未调整的模型中,HDL流出能力和HDL颗粒数量与LRNC斑块的患病率呈负相关(比值比:0.5;95%置信区间:0.26,0.96),但在多变量调整后则不然。HDL颗粒大小与LRNC斑块的患病率无关。HDL颗粒大小与HDL流出能力显著相关,这表明HDL流出能力的差异可能归因于HDL颗粒的结构差异。需要进一步的研究来确定HDL流出是否是老年人群ASCVD风险的标志物。